Home > Insider Trading > Filing (0001104659-22-013142)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1875558	Nuvectis Pharma Inc.	NVCT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1251213	Ron Bentsur	C/O Nuvectis Pharma, Inc. 1 Bridge Plaza, Suite 275 Fort Lee NJ 07024	Chairman & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value $0.00001	Acquisiton	2022-02-04	200,000	$5.00	2,765,459	No	4	P	Direct
Common Stock, Par Value $0.00001	Acquisiton	2022-02-04	12,500	$3.89	2,777,959	No	4	P	Direct
Common Stock, Par Value $0.00001	Acquisiton	2022-02-07	14,000	$3.93	2,791,959	No	4	P	Direct
Common Stock, Par Value $0.00001	Acquisiton	2022-02-07	6,000	$8.25	2,797,959	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Reflects the price of shares of common stock purchased by Mr. Bentsur in Nuvectis Pharma's initial public offering.
Includes 96,759 shares of restricted stock.
Reflects the weighted average purchase price. The range of prices for the shares purchased was $3.83 to $3.95. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
Reflects the weighted average purchase price. The range of prices for the shares purchased was $3.60 to $4.25. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.